ECG Interpretation Tools Compared – Why PMcardio Stands Out

  • Powerful Medical
  • May 6, 2025
  • 7 min to read
PMcardio versus GE HealthCare and Philips versus ChatGPT and Gemini ECG interpretation tool comparison

Interpreting ECGs accurately and swiftly is essential for clinicians at every frontline patient encounter—from primary care to emergency settings. Choosing the appropriate interpretation tool significantly impacts patient outcomes. Today, we explore three accessible solutions for clinicians: Conventional ECG Algorithms, General AI language models like ChatGPT, and PMcardio.

Interpreting ECGs accurately and swiftly is essential for clinicians at every frontline patient encounter—from primary care to emergency settings. Choosing the appropriate interpretation tool significantly impacts patient outcomes. Today, we explore three accessible solutions for clinicians: Conventional ECG Algorithms, General AI language models like ChatGPT, and PMcardio.

How do ECG Interpretation Tools Differ?

1. Conventional ECG Algorithms (e.g., GE HealthCare, Philips, Glasgow Algorithm)

Key Features:

    • Statistical analysis based on limited ECG fiducial points and a set of hand-crafted rules derived from relatively small datasets (hundreds to thousands of ECGs).
    • Automated interpretations printed directly on ECG reports.

Pros:

    • Immediately available at the ECG recording.
    • Integrated within ECG machines.
    • Operates offline, without needing an internet connection.
    • Commonly available in emergency departments.

Cons:

    • Limited to newer, digital ECG machines.
    • Often vague, non-specific interpretations.
    • Reduced accuracy in noisy or atypical ECG cases.
    • Provides limited actionable clinical information.

2. General AI Tools (e.g., ChatGPT, Gemini)

Key Features:

    • Broad AI trained on general data, not specifically medical.
    • Natural language interpretation and dialogue capabilities.

Pros:

    • Versatile use for preliminary differential diagnosis.
    • Accessible through mobile devices and web applications.
    • Helpful for general patient management options.

Cons:

    • Not specialized for ECG interpretation.
    • High risk of inaccuracies and hallucinations, potentially causing misdiagnosis.
    • Lack of clinical validation and regulatory approval.
    • Inconsistent performance and reliability.

3. PMcardio: Specialized Deep Neural Network for ECG

Key Features:

    • Advanced Deep Neural Network trained on millions of ECG cases.
    • Clinical validation against rigorous, core-lab outcomes.
    • Detects up to 49 different conditions.
    • Certified medical device ensuring high clinical standards.

Pros:

    • Compatible with any 12-lead ECG (image or paperform).
    • Does not require complex clinical integration.
    • Highly accurate, especially in challenging or noisy ECG conditions.
    • Explainable AI diagnostics with intuitive visual heatmaps.

Cons:

    • Requires a stable internet connection.

Real-World Comparison: One Patient, Three Interpretations

Patient Scenario

    • Patient Background: A 70-year-old woman presents to the emergency room with progressively worsening chest pain. She has a history of hypertension and hyperlipidemia.
    • Actual Diagnosis: Acute Infero-Posterior STEMI due to proximal total occlusion of the Left Circumflex (LCx) artery.
    • Clinical course: Delayed diagnosis resulted from incorrect ECG interpretation, causing coronary angiography to be performed 24 hours later. Detailed ECG and angiogram are available here.
12-lead ECG of infero-posterior STEMI from LCx occlusion misread by conventional algorithm as non-specific abnormal ECG

12-lead ECG recorded at a non-PCI capable spoke center’s emergency room triage bay.

ECG Interpretations Compared

Conventional Algorithm, GE Marquette 12SL (used prospectively):

    • “Sinus rhythm, Prolonged PR-interval, Normal cardiac axis, T-wave abnormality (inversion), T-wave abnormality in high-lateral leads, Non-specific ST-segment changes (depression), Abnormal ECG.”
    • Impact: Delay in diagnosis, false reassurance, emergency room physicians’ note reads: “No signs of acute ischemia, ST depression V3-V4”

Large Language Model, ChatGPT (not used prospectively in this case):

    • “The ECG demonstrates sinus rhythm with a ventricular rate of approximately 60 beats per minute. The QRS axis is within normal limits. PR interval, QRS duration, and QT interval are normal. There is mild concave-up ST-segment elevation most evident in leads V2 through V4, consistent with an early repolarization pattern, without reciprocal ST-segment depressions. Overall, this ECG represents a benign early repolarization variant without evidence of acute ischemia or other acute abnormalities. Clinical correlation is advised.”
    • Impact: Complete hallucination, there is no ST-elevation in V2-V4, but ST depression, false conclusion of benign early repolarization that could have led to further delays or unsafe discharge.

PMcardio Interpretation (not used prospectively in this case):

    • “STEMI / STEMI equivalent detected. Immediate invasive strategy or equivalent management is recommended.”
    • Impact: Clear, actionable diagnosis that could have saved valuable door-to-balloon time. AI explainability shows which leads and ECG patterns have led to the positive diagnosis.
PMcardio Core AI flagging STEMI equivalent with blue explainability heatmaps highlighting leads V2 and V3

Learn more about PMcardio’s AI explainablity feature (blue heatmaps) here: powerfulmedical.com/blog/the-explainability-feature-in-pmcardio-with-human-centered-design-in-mind

Key Takeaway Table

Feature Category PMcardio Conventional ECG Algorithms General AI (ChatGPT)
Technology ✅ Deep Neural Network ❌ Hand-crafted features ❌ Non-specialized AI
Training Dataset Size ✅ Millions of ECGs ❌ Usually Hundreds of ECGs ❌ Not specialized
Consistency ✅ Consistent* ✅ Consistent ❌ Inconsistent
Robustness ✅ Excellent (Noise/Edge Cases) ❌ Poor ❌ Very poor (hallucinations)
Regulatory Certification ✅ Certified Medical Device ✅ Certified Medical Device ❌ Not certified

*Note: When you scan an ECG more than once, especially at different angles or under varying lighting, each resulting digitized ECG waveform is technically unique. These slight differences can produce minor variations in the diagnostic output. Digital ECGs, however, are fully consistent, as they preserve exact waveform data without visual variability.

Conclusion: Why PMcardio is the First Choice of 100,000 Clinicians

Clinicians who prioritize accuracy, reliability, and rapid, explainable AI diagnosis choose PMcardio. Its specialized AI, rigorous validation, and robust diagnostic performance set it clearly apart from conventional methods and general AI tools for ECG interpretation.

Interested in PMcardio?

Discover how PMcardio can transform your clinical workflow today. Try PMcardio for Individuals for FREE today, or schedule a demo to learn more about our offering for Hospitals and Enterprises.

Share this article

  • Share on Facebook
  • Share on X
  • Share on Linkedin
  • Share via e-mail
  • Copy the link
About PMcardio logo

About PMcardio

PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.

About Product

About Powerful Medical  logo

About Powerful Medical

Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.

About Us